Zoledronic acid increases docetaxel cytotoxicity through pMEK and Mcl-1 inhibition in a hormone-sensitive prostate carcinoma cell line

  • Francesco Fabbri, Giovanni Brigliadori, Silvia Carloni, Paola Ulivi, Ivan Vannini, Anna Tesei, Rosella Silvestrini, Dino Amadori, Wainer Zoli
  • Journal of Translational Medicine, January 2008, Springer Science + Business Media
  • DOI: 10.1186/1479-5876-6-43

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1186/1479-5876-6-43

The following have contributed to this page: Dr Anna Tesei